文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

阳性qSOFA标准在急诊就诊早期预测危重脓毒症患者28天死亡率的准确性低

Low Accuracy of Positive qSOFA Criteria for Predicting 28-Day Mortality in Critically Ill Septic Patients During the Early Period After Emergency Department Presentation.
PubMed 文献 · Ann Emerg Med · 2017-06-29
一句话结论在急诊就诊早期,阳性qSOFA评分预测危重脓毒症患者28天死亡率的诊断性能低,AUC仅0.57–0.61。

这项回顾性队列研究在三级学术中心纳入1395例急诊就诊的严重脓毒症或脓毒性休克成人患者,评估阳性qSOFA评分(初始24小时内同时满足3项标准中至少2项)预测28天死亡率的诊断性能。总体28天死亡率为15%,阳性qSOFA患者28天死亡率在急诊到达时为23%,3小时为20%,6小时为20%,24小时为17%。阳性qSOFA预测28天死亡率的敏感度从急诊到达时的39%升至24小时内的91%,但特异度从77%降至23%,AUC在0.57–0.61之间。作者结论认为诊断性能低,尤其急诊就诊早期,并因回顾性设计和单中心数据需进一步前瞻性验证。

要点

  • 急诊到达时阳性qSOFA预测28天死亡率敏感度仅39%(95%CI 32%–46%),AUC 0.58(95%CI 0.55–0.62),早期识别能力低。
  • 随时间推移敏感度升高但特异度下降:3小时敏感度68%、特异度52%;6小时82%、41%;24小时91%、23%。
  • 阳性qSOFA患者28天死亡率在急诊到达时为23%(95%CI 19%–28%),24小时为17%(95%CI 15%–20%)。
  • 总体28天死亡率为15%,研究纳入1395例急诊严重脓毒症或脓毒性休克成人患者。
  • 作者认为该评分在急诊就诊早期预测28天死亡率性能低,需进一步前瞻性验证。

适用人群与场景

  • 成人(≥18岁)患者在急诊就诊期间被诊断为严重脓毒症或脓毒性休克,就诊时间为2008年8月至2014年9月。

诊断标准与关键阈值

  • 阳性qSOFA评分定义为初始24小时内同时满足3项qSOFA标准中至少2项。

研究设计与关键结果

  • 回顾性队列研究,纳入1395例急诊严重脓毒症或脓毒性休克成人患者,总体28天死亡率为15%。
  • 阳性qSOFA患者28天死亡率:急诊到达时23%(95%CI 19%–28%),3小时20%(95%CI 17%–23%),6小时20%(95%CI 17%–22%),24小时17%(95%CI 15%–20%)。
  • 阳性qSOFA预测28天死亡率的敏感度、特异度、AUC:急诊到达时39%(95%CI 32%–46%)、77%(95%CI 75%–80%)、0.58(95%CI 0.55–0.62);3小时内68%(95%CI 62%–75%)、52%(95%CI 49%–55%)、0.60(95%CI 0.57–0.63)。
  • 6小时内敏感度82%(95%CI 76%–87%)、特异度41%(95%CI 38%–44%)、AUC 0.61(95%CI 0.58–0.64);24小时内敏感度91%(95%CI 86%–94%)、特异度23%(95%CI 21%–25%)、AUC 0.57(95%CI 0.54–0.59)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:回顾性设计;单中心数据;作者指出需进一步前瞻性验证。

对床旁实践的改变

  • 作者认为阳性qSOFA评分在急诊就诊早期预测危重脓毒症患者28天死亡率性能低,尤其就诊早期。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We determine the diagnostic performance of positive Quick Sequential Organ Failure Assessment (qSOFA) scores for predicting 28-day mortality among critically ill septic patients during the early period after emergency department (ED) presentation.

METHODS: This was a retrospective cohort study at a tertiary care academic center. We reviewed a registry of adult (≥18 years) patients who received a diagnosis of severe sepsis or septic shock during an ED stay from August 2008 through September 2014. We identified the point at which patients met 2 or more of the 3 qSOFA criteria (indicating a positive qSOFA score) simultaneously during the initial 24 hours. The diagnostic performance of positive qSOFA score for predicting 28-day mortality was assessed (on ED arrival and within 3, 6, and 24 hours after ED presentation).

RESULTS: A total of 1,395 patients were included, and the overall 28-day mortality was 15%. For patients with positive qSOFA score, 28-day mortality was 23% (95% confidence interval [CI] 19% to 28%) on ED arrival, 20% (95% CI 17% to 23%) at 3 hours, 20% (95% CI 17% to 22%) at 6 hours, and 17% (95% CI 15% to 20%) at 24 hours. Positive qSOFA score for predicting 28-day mortality had a sensitivity, specificity, and area under the receiver operating curve, respectively, of 39% (95% CI 32% to 46%), 77% (95% CI 75% to 80%), and 0.58 (95% CI 0.55 to 0.62) on ED arrival; 68% (95% CI 62% to 75%), 52% (95% CI 49% to 55%), and 0.60 (95% CI 0.57 to 0.63) within 3 hours; 82% (95% CI 76% to 87%), 41% (95% CI 38% to 44%), and 0.61 (95% CI 0.58 to 0.64) within 6 hours; and 91% (95% CI 86% to 94%), 23% (95% CI 21% to 25%), and 0.57 (95% CI 0.54 to 0.59) within 24 hours.

CONCLUSION: The diagnostic performance of positive qSOFA score for predicting 28-day mortality was low in critically ill septic patients, particularly during the early period after ED presentation. The study requires further prospective validation because of limitations with its retrospective design and use of single-center data.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hwang SY, Jo IJ, Lee SU, et al. Low Accuracy of Positive qSOFA Criteria for Predicting 28-Day Mortality in Critically Ill Septic Patients During the Early Period After Emergency Department Presentation. Ann Emerg Med. 2017. PMID: 28669551. doi:10.1016/j.annemergmed.2017.05.022

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。